港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

巨子生物

60.900

-10.500-14.71%

成交量：647.89萬

成交額：4.10億

市值：630.92億

市盈率：27.42

高：67.500

開：67.450

低：60.300

收：71.400

資料載入中...

總覽公司新聞公告

鉅子生物盤中異動股價大漲5.07%報48.700港元

南向資金1月8日淨賣出鉅子生物91.55萬股連續5日減持

大摩：予鉅子生物“增持”評級目標價65港元

【大摩：予鉅子生物(02367.HK)“增持”評級目標價65港元】摩根士丹利發佈研究報告稱，預期鉅子生物(02367.HK)未來15天股價有約70%至80%錄得上升，並將其目標價定於65港元，給予“增持”評級。該行預計公司2024及2025財年的盈利增長，將分別為37%和23%，即將公佈的全年業績或較該行覆蓋範圍內的其他公司更強。

大摩：予鉅子生物(02367)“增持”評級目標價65港元

招銀國際：政策持續發力看好中國醫藥估值反彈

鉅子生物01月08日主力資金流出934萬元連續3日減倉

【券商聚焦】招銀國際指醫藥行業受益於海外降息以及國內宏觀環境改善有望在2025年跑贏市場

大摩：鉅子生物未來15天股價有約70%至80%上升目標價為65港元

《大行》大摩料鉅子生物(02367.HK)未來15天股價上升評級“增持”

阿斯达克财经

南向資金1月6日淨賣出鉅子生物19.44萬股連續3日減持

美護行業25年年度策略報告：強者恆強小而美賽道值得期待

中邮证券有限责...

鉅子生物(2367.HK)：骨修復材料創新突破醫美產品未來可期

業績減速苗頭初現，錦波生物難留在舒適圈

鉅子生物12月19日遭主力拋售445萬元環比增加1248.48%

鉅子生物增資至6.9億增幅約110%

南方财经网

【券商聚焦】華泰證券升鉅子生物(02367)目標價23.5% 指醫美產品若獲批可能有較大業績釋放潛力

【券商聚焦】國金證券維持鉅子生物(02367)“買入”評級指其醫美明年預期落地

套現近100億，鉅子生物高調上市背後的“資本騰挪”之道

储凡朋友圈

國金證券：維持鉅子生物(02367)“買入”評級骨修復材料獲批三類械

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02367/news?page=7"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02367","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02367\",,,,,undefined,":{"symbol":"02367","market":"HK","secType":"STK","nameCN":"巨子生物","latestPrice":60.9,"timestamp":1744013346017,"preClose":71.4,"halted":0,"volume":6478917,"delay":0,"floatShares":1036000000,"shares":1036000000,"eps":2.2213861716385446,"marketStatus":"未開盤","change":-10.5,"latestTime":"04-07 16:09:06","open":67.45,"high":67.5,"low":60.3,"amount":409801047,"amplitude":0.10084,"askPrice":60.95,"askSize":15000,"bidPrice":60.9,"bidSize":14800,"shortable":3,"etf":0,"ttmEps":2.1787109152760946,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1744075800000},"marketStatusCode":0,"adr":0,"listingDate":1667491200000,"exchange":"SEHK","adjPreClose":71.4,"dividendRate":0.015928,"openAndCloseTimeList":[[1743989400000,1743998400000],[1744002000000,1744012800000]],"volumeRatio":1.4184404879578902,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02367\",,,,,undefined,":{"symbol":"02367","floatShares":1036000000,"roa":"21.88%","roe":"35.88%","lyrEps":2.221386,"volumeRatio":1.4184404879578902,"shares":1036000000,"dividePrice":0.97,"high":67.5,"amplitude":0.10084,"preClose":71.4,"low":60.3,"week52Low":35,"pbRate":"8.39","psRate":"10.77","week52High":75.2,"institutionHeld":0,"latestPrice":60.9,"committee":-0.006711,"eps":2.2213861716385446,"divideRate":0.015928,"volume":6478917,"delay":0,"ttmEps":2.1787109152760946,"open":67.45,"prevYearClose":49.9,"prevWeekClose":71.4,"prevMonthClose":70.45,"prevQuarterClose":70.45,"fiveDayClose":68,"twentyDayClose":69.3,"sixtyDayClose":46.7},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02367\",pageSize:20,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2502968268","title":"鉅子生物盤中異動 股價大漲5.07%報48.700港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502968268","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502968268?lang=zh_tw&edition=fundamental","pubTime":"2025-01-10 09:30","pubTimestamp":1736472623,"startTime":"0","endTime":"0","summary":"2025年01月10日早盘09时30分，巨子生物股票出现异动，股价大幅上涨5.07%。截至发稿，该股报48.700港元/股，成交量9200股，换手率0.00%，振幅3.88%。资金方面，该股资金流入19.175万港元，流出6.566万港元。巨子生物股票所在的生物技术行业中，整体涨幅为0.23%。该信息摘要如下：摩根士丹利发布研究报告称，预期巨子生物未来15天股价有约70%至80%录得上升，并将其目标价定于65港元，给予“增持”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011009302398610724&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011009302398610724&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","02367","BK1207"],"gpt_icon":0},{"id":"2502354034","title":"南向資金1月8日淨賣出鉅子生物91.55萬股 連續5日減持","url":"https://stock-news.laohu8.com/highlight/detail?id=2502354034","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502354034?lang=zh_tw&edition=fundamental","pubTime":"2025-01-09 09:30","pubTimestamp":1736386222,"startTime":"0","endTime":"0","summary":"1月8日，南向资金减持巨子生物91.55万股连续5日减持。截止当日收盘，港股通共持有巨子生物16881.92万股，占流通股16.41%。港股通减持金额前五个股分别为小鹏汽车-W、华润啤酒、碧桂园服务、雅迪控股、安踏体育。巨子生物近5个交易日下跌7.31%，港股通累计减持182.33万股；近20个交易日下跌9.84%，港股通累计减持381.68万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109093259aba3dc74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109093259aba3dc74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","02367","LU2488822045.USD"],"gpt_icon":0},{"id":"2501743860","title":"大摩：予鉅子生物“增持”評級 目標價65港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501743860","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501743860?lang=zh_tw&edition=fundamental","pubTime":"2025-01-08 17:09","pubTimestamp":1736327340,"startTime":"0","endTime":"0","summary":"　　摩根士丹利发布研究报告称，预期巨子生物未来15天股价有约70%至80%录得上升，并将其目标价定于65港元，给予“增持”评级。该行预计公司2024及2025财年的盈利增长，将分别为37%和23%，即将公布的全年业绩或较该行覆盖范围内的其他公司更强。　　报告中称，巨子生物股价自去年12月中旬以来已下跌约12%，该行暂未看到根本原因，但认为相关表现主要受市场配置所影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2025-01-08/doc-ineehfmt0430836.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02367"],"gpt_icon":0},{"id":"2501710704","title":"【大摩：予鉅子生物(02367.HK)“增持”評級 目標價65港元】摩根士丹利發佈研究報告稱，預期鉅子生物(02367.HK)未來15天股價有約70%至80%錄得上升，並將其目標價定於65港元，給予“增持”評級。該行預計公司2024及2025財年的盈利增長，將分別為37%和23%，即將公佈的全年業績或較該行覆蓋範圍內的其他公司更強。","url":"https://stock-news.laohu8.com/highlight/detail?id=2501710704","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501710704?lang=zh_tw&edition=fundamental","pubTime":"2025-01-08 16:59","pubTimestamp":1736326785,"startTime":"0","endTime":"0","summary":"摩根士丹利发布研究报告称，预期巨子生物(02367.HK)未来15天股价有约70%至80%录得上升，并将其目标价定于65港元，给予“增持”评级。该行预计公司2024及2025财年的盈利增长，将分别为37%和23%，即将公布的全年业绩或较该行覆盖范围内的其他公司更强。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/08165947255704.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02367"],"gpt_icon":0},{"id":"2501571022","title":"大摩：予鉅子生物(02367)“增持”評級 目標價65港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501571022","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501571022?lang=zh_tw&edition=fundamental","pubTime":"2025-01-08 16:56","pubTimestamp":1736326578,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，摩根士丹利发布研究报告称，预期巨子生物(02367)未来15天股价有约70%至80%录得上升，并将其目标价定于65港元，给予“增持”评级。该行预计公司2024及2025财年的盈利增长，将分别为37%和23%，即将公布的全年业绩或较该行覆盖范围内的其他公司更强。报告中称，巨子生物股价自去年12月中旬以来已下跌约12%，该行暂未看到根本原因，但认为相关表现主要受市场配置所影响。该行认为，若以2025年预计的18倍市盈率交易，可以看到令人信服的风险及回报，因为该公司业务仍处于强劲的扩张周期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1234895.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02367"],"gpt_icon":0},{"id":"2501371720","title":"招銀國際：政策持續發力 看好中國醫藥估值反彈","url":"https://stock-news.laohu8.com/highlight/detail?id=2501371720","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501371720?lang=zh_tw&edition=fundamental","pubTime":"2025-01-08 16:34","pubTimestamp":1736325258,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，招银国际发布研报称，受益于海外降息以及国内宏观环境改善，医药作为高弹性行业有望在2025年跑赢市场。随着医疗设备招标大幅复苏，看好招标恢复的持续性，看好行业估值修复。国办再发文支持创新药械1月3日，国务院办公厅发布《关于全面深化药品医疗器械监管改革促进医药产业高质量发展的意见》。医疗设备招标大幅复苏，看好招标恢复的持续性根据众成数科统计，12月全国医疗器械公开招中标市场规模同比增长37%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1234865.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1046422090.SGD","LU2045819591.USD","LU2488822045.USD","01801","BK1589","LU2328871848.SGD","BK0010","LU2242644610.SGD","BK0185","BK1161","BK0028","LU0052750758.USD","LU2125910500.SGD","BK0250","LU0320764599.SGD","BK0188","02367","BK1576","BK1593","BK1583","LU0196878994.USD","LU0708995583.HKD","06990","BK1207","BK0082","LU1969619763.USD","BK0175","01530","600056","BK1141","02359"],"gpt_icon":0},{"id":"2501330748","title":"鉅子生物01月08日主力資金流出934萬元 連續3日減倉","url":"https://stock-news.laohu8.com/highlight/detail?id=2501330748","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501330748?lang=zh_tw&edition=fundamental","pubTime":"2025-01-08 16:15","pubTimestamp":1736324132,"startTime":"0","endTime":"0","summary":"01月08日, 巨子生物股价跌0.96%，报收46.25元，成交金额9894万元，换手率0.21%，振幅3.00%，量比0.70。巨子生物今日主力资金净流出934万元，连续3日净流出，上一交易日主力净流出871万元，今日环比增加7.23%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为35.29%，平均跌幅为0.32%。该股近5个交易日下跌8.32%，主力资金累计净流出3052万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出1198万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108161551a219e48d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108161551a219e48d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02367","BK1207","LU2488822045.USD"],"gpt_icon":0},{"id":"2501471482","title":"【券商聚焦】招銀國際指醫藥行業受益於海外降息以及國內宏觀環境改善 有望在2025年跑贏市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2501471482","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501471482?lang=zh_tw&edition=fundamental","pubTime":"2025-01-08 15:41","pubTimestamp":1736322113,"startTime":"0","endTime":"0","summary":"近期，中国创新药出海交易继续快速增长，例如信达生物和恒瑞医药分别与罗氏和IDEAYA Biosciences达成了关于DLL3ADC的海外授权交易，交易总额均超过10亿美金。该行认为，受益于海外降息以及国内宏观环境改善，医药作为高弹性行业有望在2025年跑赢市场。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1951004","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1207","LU2488822045.USD","BK1500","HK0000934320.USD","LU2125910500.SGD","LU1969619763.USD","BK1583","LU0708995583.HKD","02367","BK1576","LU2328871848.SGD","06160","LU0320764599.SGD","01801","BK1589","LU0052750758.USD","BK1593","LU2045819591.USD","LU1046422090.SGD","06990","BK1588","BK1161","LU0588546209.SGD","01530","LU0307460666.USD","BK1141","02359","LU0196878994.USD","LU2242644610.SGD"],"gpt_icon":0},{"id":"2501971419","title":"大摩：鉅子生物未來15天股價有約70%至80%上升 目標價為65港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501971419","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501971419?lang=zh_tw&edition=fundamental","pubTime":"2025-01-08 15:38","pubTimestamp":1736321929,"startTime":"0","endTime":"0","summary":"摩根士丹利发表研报指，若以2025年预计的18倍市盈率交易，可以看到巨子生物令人信服的风险及回报，该公司业务仍处于强劲的扩张周期。该行预计，巨子生物2024及2025财年的盈利增长，将分别为37%和23%，即将公布的全年业绩或较该行覆盖范围内的其他公司更强。大摩预期，巨子生物未来15天股价有约70%至80%录得上升，并将其目标价定于65港元，给予“增持”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108155407aba2d67b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108155407aba2d67b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02367"],"gpt_icon":0},{"id":"2501157007","title":"《大行》大摩料鉅子生物(02367.HK)未來15天股價上升  評級“增持”","url":"https://stock-news.laohu8.com/highlight/detail?id=2501157007","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501157007?lang=zh_tw&edition=fundamental","pubTime":"2025-01-08 14:57","pubTimestamp":1736319420,"startTime":"0","endTime":"0","summary":"摩根士丹利发表研报指，巨子生物股价自去年12月中旬以来已下跌约12%，该行暂未看到根本原因，但认为相关表现主要受市场配置所影响。该行预计，巨子生物2024及2025财年的盈利增长，将分别为37%和23%，即将公布的全年业绩或较该行覆盖范围内的其他公司更强。大摩预期，巨子生物未来15天股价有约70%至80%录得上升，并将其目标价定于65元，给予“增持”评级。沽空资料截至 2025-01-08 12:25。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20221209170600934_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20221209170600934_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1408835/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02367"],"gpt_icon":0},{"id":"2501421500","title":"南向資金1月6日淨賣出鉅子生物19.44萬股 連續3日減持","url":"https://stock-news.laohu8.com/highlight/detail?id=2501421500","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501421500?lang=zh_tw&edition=fundamental","pubTime":"2025-01-07 09:30","pubTimestamp":1736213423,"startTime":"0","endTime":"0","summary":"1月6日，南向资金减持巨子生物19.44万股连续3日减持。截止当日收盘，港股通共持有巨子生物17027.79万股，占流通股16.55%。港股通减持金额前五个股分别为舜宇光学科技、吉利汽车、中芯国际、友邦保险、小米集团-W。巨子生物近5个交易日下跌7.46%，港股通累计减持47.72万股；近20个交易日下跌4.91%，港股通累计减持244.33万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107093314a2182603&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107093314a2182603&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","LU2488822045.USD","02367"],"gpt_icon":0},{"id":"2494014754","title":"美護行業25年年度策略報告：強者恆強 小而美賽道值得期待","url":"https://stock-news.laohu8.com/highlight/detail?id=2494014754","media":"中邮证券有限责...","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494014754?lang=zh_tw&edition=fundamental","pubTime":"2024-12-25 00:00","pubTimestamp":1735056000,"startTime":"0","endTime":"0","summary":"投资要点行情回顾：板块年初至今小幅下跌，估值有所回落。标的上我们重点推荐估值回落+产品布局全的一线龙头爱美客以及胶原蛋白产品25年迎来新进展的巨子生物，关注再生类产品持续放量+产品布局全面的江苏吴中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122516030395ec1fb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122516030395ec1fb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","02367","LU2488822045.USD"],"gpt_icon":0},{"id":"2493246282","title":"鉅子生物(2367.HK)：骨修復材料創新突破 醫美產品未來可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2493246282","media":"西部证券","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493246282?lang=zh_tw&edition=fundamental","pubTime":"2024-12-22 00:00","pubTimestamp":1734796800,"startTime":"0","endTime":"0","summary":"获批骨修复材料III 类医疗器械注册证，实现严肃医疗领域技术突破。公司自主研发的骨修复材料成功获得国家药监局 III 类医疗器械注册证，为骨缺损修复领域提供了全新解决方案。化妆品表现强势，医美产品未来可期。后续产品上市后将进一步打通化妆品与医美领域的联动路径，为抗衰老和修复市场带来高技术壁垒的创新解决方案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241222205030a202298a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241222205030a202298a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","02367","LU2488822045.USD"],"gpt_icon":0},{"id":"2492656144","title":"業績減速苗頭初現，錦波生物難留在舒適圈","url":"https://stock-news.laohu8.com/highlight/detail?id=2492656144","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492656144?lang=zh_tw&edition=fundamental","pubTime":"2024-12-19 17:22","pubTimestamp":1734600160,"startTime":"0","endTime":"0","summary":"作为北交所的明星公司，锦波生物堪称行业典范，业绩前几年稳定高增长，股价最大涨幅超过15倍，盈利水平之高被市场称为“超越茅台的公司”。在医美赛道整体偏弱的情况下，锦波生物独树一帜。不过，从半年报看出，锦波生物旗下主力产品薇旖美收入同比增幅较去年同期出现明显放缓，并且这个赛道中还有巨子生物、江苏吴中、创建医疗等一大批竞争对手，要维持高毛利的同时还要抢占市场，锦波生物能留在舒适圈的时间还有多久？","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/247339","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["09997","02367","09996","BK1574","LU2488822045.USD","BK1583","BK1207","BK1100","BK1222"],"gpt_icon":0},{"id":"2492142884","title":"鉅子生物12月19日遭主力拋售445萬元 環比增加1248.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492142884","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492142884?lang=zh_tw&edition=fundamental","pubTime":"2024-12-19 16:15","pubTimestamp":1734596148,"startTime":"0","endTime":"0","summary":"12月19日, 巨子生物股价跌0.38%，报收51.75元，成交金额1.29亿元，换手率0.24%，振幅4.33%，量比0.77。巨子生物今日主力资金净流出445万元，连续3日净流出，上一交易日主力净流出33万元，今日环比增加1248.48%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为35.29%，平均跌幅为2.41%。该股近5个交易日下跌2.53%，主力资金累计净流出872万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流入8893万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219162634ab83efc5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219162634ab83efc5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","02367","BK1207"],"gpt_icon":0},{"id":"2492114152","title":"鉅子生物增資至6.9億 增幅約110%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492114152","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492114152?lang=zh_tw&edition=fundamental","pubTime":"2024-12-19 14:48","pubTimestamp":1734590901,"startTime":"0","endTime":"0","summary":"南方财经12月19日电，天眼查App显示，近日，巨子生物（HK.02367）发生工商变更，注册资本由约3.3亿人民币增至约6.9亿人民币，增幅约110%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412193273220777.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02367","BK1207","LU2488822045.USD"],"gpt_icon":0},{"id":"2492119611","title":"【券商聚焦】華泰證券升鉅子生物(02367)目標價23.5% 指醫美產品若獲批可能有較大業績釋放潛力","url":"https://stock-news.laohu8.com/highlight/detail?id=2492119611","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492119611?lang=zh_tw&edition=fundamental","pubTime":"2024-12-19 14:04","pubTimestamp":1734588293,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华泰证券发研报指，17日巨子生物 公众号披露获得首个III类医疗器械注册证，为骨修复材料。参考锦波生物、爱美客，后续公司眼部细纹、颈纹产品若能获批可能会带来较大业绩增量。该行预计24-26年归母净利润至19.98/25.10/30.78亿元（维持），可比公司Wind一致盈利预测25PE均值26倍，考虑医美产品若获批可能有较大业绩释放潜力，给予25年28倍PE，目标价HKD73.96元，前值HKD59.89元，维持买入。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/Y2EzOTlkNjExODQ0M2ZhODVjNjcxNDk5OTNhMDU4MjE2MzgxODI2NTQy.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/Y2EzOTlkNjExODQ0M2ZhODVjNjcxNDk5OTNhMDU4MjE2MzgxODI2NTQy.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1949965","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06886","02367"],"gpt_icon":0},{"id":"2492116956","title":"【券商聚焦】國金證券維持鉅子生物(02367)“買入”評級 指其醫美明年預期落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2492116956","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492116956?lang=zh_tw&edition=fundamental","pubTime":"2024-12-19 13:58","pubTimestamp":1734587930,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国金证券发研指，巨子生物 近日官网公示，其骨修复材料获批三类医疗器械，符合此前招股书24Q4拿证预期。该行表示，妆品持续完善多单品矩阵，医美明年预期落地。考虑双十一线上表现亮眼，上调公司盈利预测，预计24-26年经调整净利润20.9/25.5/30.6亿元、同增43%/22%/20%，归母净利润20/24.6/29.7亿元，同增38%/23%/21%、对应PE25/20/17倍，维持“买入”评级。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1949964","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"gpt_icon":0},{"id":"2492185422","title":"套現近100億，鉅子生物高調上市背後的“資本騰挪”之道","url":"https://stock-news.laohu8.com/highlight/detail?id=2492185422","media":"储凡朋友圈","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492185422?lang=zh_tw&edition=fundamental","pubTime":"2024-12-18 21:30","pubTimestamp":1734528647,"startTime":"0","endTime":"0","summary":"值得注意的是，巨子生物还在上市前连续三年实施大额分红。换句话说，巨子生物的大股东已经提前将这部分利润进行了“套现”，以免被后续进入的投资人分走。2021年10月13日相关减资及购回股份完成后，西安巨子生物由范博士和GSUM XV HK Holdings Limited分别持有98.91%和1.09%的股本权益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218213257ab81eb3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218213257ab81eb3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","02367","LU2488822045.USD"],"gpt_icon":0},{"id":"2492773789","title":"國金證券：維持鉅子生物(02367)“買入”評級 骨修復材料獲批三類械","url":"https://stock-news.laohu8.com/highlight/detail?id=2492773789","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492773789?lang=zh_tw&edition=fundamental","pubTime":"2024-12-18 17:14","pubTimestamp":1734513264,"startTime":"0","endTime":"0","summary":"事件：国家药监局12月17日官网公示，巨子生物骨修复材料获批三类医疗器械，符合此前招股书24Q4拿证预期。供给端看，据药监局，除巨子生物外，奥精医疗科技、天津市赛宁生物等旗下的胶原蛋白+羟基磷灰石复合的骨修复材料已获批三类械。2)国内获批进展：目前羟基磷灰石材料在国内医美领域尚无合规三类证。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226535.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02367"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02367\",params:#limit:5,,,undefined,":[{"date":"2025-06-17","symbol":"02367","amount":0.5921,"announcedDate":"2025-03-26","type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2025-06-18","defaultRemindTime":1750123800000,"name":"巨子生物","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-29","payableDate":"2025-06-18","currency":"CNY","dateTimestamp":1750089600000,"payDate":"2025-08-29"},{"date":"2025-03-26","symbol":"02367","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742952600000,"name":null,"time":"盤後","dateTimestamp":1742918400000,"actualEps":null},{"date":"2024-08-19","symbol":"02367","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724031000000,"name":null,"time":"盤後","dateTimestamp":1723996800000,"actualEps":null},{"date":"2024-06-17","symbol":"02367","amount":0.97,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2024-06-18","defaultRemindTime":1718587800000,"name":"巨子生物","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-05","payableDate":"2024-06-18","currency":"HKD","dateTimestamp":1718553600000,"payDate":"2024-07-05"},{"date":"2024-03-25","symbol":"02367","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02367\",market:\"HK\",,,undefined,":[{"executeDate":"2024-06-17","recordDate":"2024-06-18","paymentDate":"2024-07-05","value":0.97,"currency":"HKD"},{"executeDate":"2025-06-17","recordDate":"2025-06-18","paymentDate":"2025-08-29","value":0.5921,"currency":"CNY"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02367\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3529,"buy":0.6471,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6471,"analysts":17,"updateTime":1743350400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02367\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02367","date":"2025-04-03","current":32.960917,"percent":0.76819,"low":18.546195,"twenty":25.84406,"median":29.176551,"eighty":33.68679,"high":60.214956,"avg":30.40921,"sd":6.612573,"marketCap":72606945600},"quantilePoints":[{"date":"2022-11-04","current":28.694216,"twenty":26.512834,"median":26.542085,"eighty":27.833364,"marketCap":25968654960},{"date":"2022-11-11","current":35.577583,"twenty":27.402937,"median":34.819032,"eighty":37.211633,"marketCap":32485133920},{"date":"2022-11-18","current":30.409033,"twenty":29.071802,"median":32.325114,"eighty":36.373143,"marketCap":27670720360},{"date":"2022-11-25","current":29.089974,"twenty":29.309257,"median":30.328688,"eighty":34.970742,"marketCap":26260437600},{"date":"2022-12-02","current":29.440115,"twenty":28.58665,"median":29.786096,"eighty":33.378719,"marketCap":27035200000},{"date":"2022-12-09","current":33.170723,"twenty":28.69893,"median":30.328688,"eighty":33.541593,"marketCap":30744000000},{"date":"2022-12-16","current":33.617702,"twenty":28.859591,"median":31.890871,"eighty":33.525219,"marketCap":31085600000},{"date":"2022-12-23","current":32.235512,"twenty":29.23003,"median":32.061881,"eighty":33.375102,"marketCap":29816800000},{"date":"2022-12-30","current":35.028223,"twenty":29.440115,"median":32.235512,"eighty":33.644993,"marketCap":32793600000},{"date":"2023-01-06","current":34.259259,"twenty":29.598569,"median":32.356077,"eighty":33.906187,"marketCap":32403200000},{"date":"2023-01-13","current":37.514633,"twenty":29.683286,"median":32.593587,"eighty":35.138095,"marketCap":36160800000},{"date":"2023-01-20","current":39.320225,"twenty":29.767789,"median":33.170723,"eighty":36.075015,"marketCap":37576000000},{"date":"2023-01-27","current":41.405428,"twenty":29.847916,"median":33.242723,"eighty":36.22764,"marketCap":39576800000},{"date":"2023-02-03","current":46.017337,"twenty":30.125824,"median":33.502098,"eighty":37.981351,"marketCap":44212800000},{"date":"2023-02-10","current":48.646066,"twenty":30.280481,"median":33.687805,"eighty":39.317619,"marketCap":46457600000},{"date":"2023-02-17","current":47.305048,"twenty":30.475064,"median":33.964048,"eighty":41.148897,"marketCap":44749600000},{"date":"2023-02-24","current":46.898265,"twenty":30.969524,"median":34.88282,"eighty":44.591745,"marketCap":43822400000},{"date":"2023-03-03","current":48.206405,"twenty":31.89643,"median":35.69024,"eighty":46.759698,"marketCap":45335200000},{"date":"2023-03-17","current":60.214956,"twenty":31.932315,"median":36.041848,"eighty":47.552658,"marketCap":56754400000},{"date":"2023-03-24","current":51.699724,"twenty":32.016899,"median":36.568073,"eighty":48.347792,"marketCap":49288000000},{"date":"2023-03-31","current":40.925047,"twenty":32.156582,"median":37.514633,"eighty":48.347792,"marketCap":46848000000},{"date":"2023-04-06","current":40.652856,"twenty":32.21578,"median":38.432644,"eighty":48.279626,"marketCap":46506400000},{"date":"2023-04-14","current":37.246115,"twenty":32.289273,"median":38.307612,"eighty":48.226605,"marketCap":42651200000},{"date":"2023-04-21","current":33.385259,"twenty":32.343692,"median":38.098031,"eighty":47.893759,"marketCap":38210400000},{"date":"2023-04-28","current":30.285025,"twenty":32.289273,"median":37.591448,"eighty":47.642868,"marketCap":34404000000},{"date":"2023-05-05","current":26.161165,"twenty":31.945964,"median":37.33158,"eighty":47.490756,"marketCap":29768000000},{"date":"2023-05-12","current":30.574645,"twenty":30.692284,"median":36.23263,"eighty":47.274687,"marketCap":34550400000},{"date":"2023-05-19","current":31.711515,"twenty":30.746535,"median":35.923479,"eighty":47.115193,"marketCap":35331200000},{"date":"2023-05-25","current":31.182824,"twenty":30.822604,"median":35.69024,"eighty":46.935066,"marketCap":34599200000},{"date":"2023-06-02","current":32.039153,"twenty":30.742861,"median":35.028223,"eighty":46.759698,"marketCap":35428800000},{"date":"2023-06-09","current":32.262222,"twenty":30.684805,"median":34.15987,"eighty":46.167812,"marketCap":35624000000},{"date":"2023-06-16","current":32.772734,"twenty":30.742861,"median":33.693297,"eighty":45.892894,"marketCap":36014400000},{"date":"2023-06-23","current":31.032471,"twenty":30.757557,"median":33.682729,"eighty":45.395124,"marketCap":33916000000},{"date":"2023-06-30","current":31.360803,"twenty":30.757557,"median":33.502098,"eighty":44.617559,"marketCap":33964800000},{"date":"2023-07-07","current":31.376956,"twenty":30.759705,"median":33.358016,"eighty":44.488487,"marketCap":33916000000},{"date":"2023-07-14","current":31.254408,"twenty":30.81937,"median":33.206723,"eighty":42.385946,"marketCap":34257600000},{"date":"2023-07-21","current":29.61115,"twenty":30.759705,"median":32.931722,"eighty":41.535665,"marketCap":32305600000},{"date":"2023-07-28","current":31.165322,"twenty":30.717545,"median":32.723027,"eighty":41.405428,"marketCap":33964800000},{"date":"2023-08-04","current":32.76763,"twenty":30.739187,"median":32.639512,"eighty":41.393979,"marketCap":35770400000},{"date":"2023-08-11","current":32.773868,"twenty":30.757557,"median":32.603384,"eighty":41.176747,"marketCap":35575200000},{"date":"2023-08-18","current":30.610294,"twenty":30.757557,"median":32.513854,"eighty":41.037499,"marketCap":32988800000},{"date":"2023-08-25","current":31.726668,"twenty":30.759705,"median":32.346784,"eighty":40.925047,"marketCap":34208800000},{"date":"2023-09-01","current":27.573424,"twenty":30.671209,"median":32.32831,"eighty":40.652856,"marketCap":36697600000},{"date":"2023-09-08","current":26.75169,"twenty":30.572064,"median":32.277824,"eighty":40.648282,"marketCap":35184800000},{"date":"2023-09-15","current":25.993592,"twenty":30.285025,"median":32.235512,"eighty":40.62978,"marketCap":34452800000},{"date":"2023-09-22","current":25.737943,"twenty":29.809068,"median":32.045764,"eighty":40.128892,"marketCap":33964800000},{"date":"2023-09-29","current":25.066298,"twenty":29.656075,"median":31.997803,"eighty":39.81665,"marketCap":33135200000},{"date":"2023-10-06","current":25.484582,"twenty":29.406098,"median":31.918666,"eighty":39.533705,"marketCap":33672000000},{"date":"2023-10-13","current":24.08012,"twenty":28.952772,"median":31.841433,"eighty":39.348774,"marketCap":31768800000},{"date":"2023-10-20","current":22.598372,"twenty":28.090884,"median":31.767659,"eighty":39.309801,"marketCap":29768000000},{"date":"2023-10-27","current":22.348635,"twenty":27.619397,"median":31.711663,"eighty":39.282609,"marketCap":29426400000},{"date":"2023-11-03","current":25.394448,"twenty":27.541831,"median":31.642548,"eighty":39.168886,"marketCap":33525600000},{"date":"2023-11-10","current":25.843419,"twenty":27.016595,"median":31.492944,"eighty":38.901953,"marketCap":34111200000},{"date":"2023-11-17","current":25.355932,"twenty":26.744612,"median":31.467436,"eighty":38.544946,"marketCap":33769600000},{"date":"2023-11-24","current":25.803053,"twenty":26.578324,"median":31.402883,"eighty":38.289787,"marketCap":34648000000},{"date":"2023-12-01","current":25.805078,"twenty":26.361375,"median":31.373452,"eighty":38.186355,"marketCap":34794400000},{"date":"2023-12-08","current":23.911147,"twenty":26.187226,"median":31.314709,"eighty":38.124793,"marketCap":32110400000},{"date":"2023-12-15","current":23.015122,"twenty":25.978956,"median":31.279712,"eighty":37.928033,"marketCap":31085600000},{"date":"2023-12-22","current":23.970526,"twenty":25.934891,"median":31.256547,"eighty":37.726838,"marketCap":32354400000},{"date":"2023-12-29","current":25.605578,"twenty":25.922833,"median":31.253927,"eighty":37.637537,"marketCap":34745600000},{"date":"2024-01-05","current":24.881987,"twenty":25.805078,"median":31.237017,"eighty":37.514633,"marketCap":33525600000},{"date":"2024-01-12","current":25.701327,"twenty":25.757517,"median":31.165322,"eighty":37.417045,"marketCap":34648000000},{"date":"2024-01-19","current":24.032983,"twenty":25.700075,"median":31.138965,"eighty":37.246115,"marketCap":32354400000},{"date":"2024-01-26","current":24.563567,"twenty":25.531167,"median":31.049171,"eighty":36.903516,"marketCap":32940000000},{"date":"2024-02-02","current":22.773078,"twenty":25.419215,"median":30.993085,"eighty":36.23263,"marketCap":30500000000},{"date":"2024-02-09","current":24.329361,"twenty":25.355932,"median":30.81937,"eighty":36.207681,"marketCap":32744800000},{"date":"2024-02-16","current":25.846624,"twenty":25.369207,"median":30.758631,"eighty":36.108181,"marketCap":34794400000},{"date":"2024-02-23","current":26.457355,"twenty":25.369207,"median":30.717545,"eighty":35.899805,"marketCap":35428800000},{"date":"2024-03-01","current":26.003824,"twenty":25.387892,"median":30.635655,"eighty":35.803782,"marketCap":34843200000},{"date":"2024-03-08","current":26.210688,"twenty":25.395134,"median":30.572064,"eighty":35.667709,"marketCap":35136000000},{"date":"2024-03-15","current":30.241869,"twenty":25.409765,"median":30.44783,"eighty":35.490153,"marketCap":40504000000},{"date":"2024-03-22","current":31.217759,"twenty":25.435494,"median":30.569793,"eighty":35.18968,"marketCap":41772800000},{"date":"2024-03-28","current":26.416103,"twenty":25.461641,"median":30.551779,"eighty":34.970062,"marketCap":41528800000},{"date":"2024-04-05","current":26.713065,"twenty":25.484582,"median":30.44783,"eighty":34.88282,"marketCap":41968000000},{"date":"2024-04-12","current":27.194611,"twenty":25.506915,"median":30.285025,"eighty":34.259259,"marketCap":42748800000},{"date":"2024-04-19","current":29.268508,"twenty":25.516475,"median":30.168532,"eighty":34.060481,"marketCap":45969600000},{"date":"2024-04-26","current":29.89571,"twenty":25.531167,"median":29.89571,"eighty":33.867614,"marketCap":46896800000},{"date":"2024-05-03","current":31.286129,"twenty":25.569811,"median":29.89571,"eighty":33.72816,"marketCap":49044000000},{"date":"2024-05-10","current":35.317002,"twenty":25.600357,"median":30.150227,"eighty":34.911901,"marketCap":51288800000},{"date":"2024-05-17","current":33.551674,"twenty":25.608792,"median":30.245106,"eighty":35.034138,"marketCap":48653600000},{"date":"2024-05-24","current":33.729665,"twenty":25.66112,"median":30.409033,"eighty":35.021714,"marketCap":48800000000},{"date":"2024-05-31","current":34.458991,"twenty":25.697876,"median":30.512617,"eighty":34.936642,"marketCap":49905929000},{"date":"2024-06-07","current":35.513458,"twenty":25.700826,"median":30.572064,"eighty":35.034138,"marketCap":51369298000},{"date":"2024-06-14","current":33.485895,"twenty":25.715973,"median":30.610294,"eighty":35.023883,"marketCap":48392099000},{"date":"2024-06-21","current":32.121521,"twenty":25.745773,"median":30.694377,"eighty":34.964455,"marketCap":46323198000},{"date":"2024-06-28","current":32.099848,"twenty":25.775731,"median":30.739187,"eighty":34.884174,"marketCap":46272737000},{"date":"2024-07-05","current":29.936022,"twenty":25.803458,"median":30.671209,"eighty":34.879736,"marketCap":43144155000},{"date":"2024-07-12","current":29.087996,"twenty":25.812746,"median":30.592469,"eighty":34.858532,"marketCap":41983552000},{"date":"2024-07-19","current":27.898783,"twenty":25.84406,"median":30.569793,"eighty":34.80307,"marketCap":40267878000},{"date":"2024-07-26","current":27.412372,"twenty":25.847354,"median":30.44783,"eighty":34.722361,"marketCap":39712807000},{"date":"2024-08-02","current":26.870727,"twenty":25.853895,"median":30.347362,"eighty":34.692602,"marketCap":38905431000},{"date":"2024-08-09","current":29.53175,"twenty":25.868681,"median":30.263126,"eighty":34.580226,"marketCap":43043233000},{"date":"2024-08-16","current":27.651468,"twenty":25.880225,"median":30.20526,"eighty":34.54918,"marketCap":40318339000},{"date":"2024-08-23","current":20.295155,"twenty":25.847354,"median":30.132576,"eighty":34.503268,"marketCap":39157736000},{"date":"2024-08-30","current":21.43279,"twenty":25.766624,"median":29.936022,"eighty":34.476088,"marketCap":41630325000},{"date":"2024-09-06","current":20.565575,"twenty":25.695677,"median":29.843348,"eighty":34.445054,"marketCap":39965112000},{"date":"2024-09-13","current":18.849184,"twenty":25.540828,"median":29.786096,"eighty":34.363297,"marketCap":36533764000},{"date":"2024-09-20","current":20.082561,"twenty":25.484582,"median":29.694562,"eighty":34.259259,"marketCap":39157736000},{"date":"2024-09-27","current":24.850231,"twenty":25.394448,"median":29.657792,"eighty":34.060481,"marketCap":48745326000},{"date":"2024-10-04","current":29.382648,"twenty":25.395362,"median":29.624666,"eighty":34.023673,"marketCap":57374157000},{"date":"2024-10-10","current":27.207172,"twenty":25.409765,"median":29.557165,"eighty":33.926357,"marketCap":52782206000},{"date":"2024-10-18","current":27.08831,"twenty":25.435494,"median":29.436062,"eighty":33.784845,"marketCap":52277596000},{"date":"2024-10-25","current":27.691447,"twenty":25.469288,"median":29.344363,"eighty":33.707844,"marketCap":53438199000},{"date":"2024-11-01","current":28.012496,"twenty":25.497982,"median":29.274876,"eighty":33.690002,"marketCap":54094192000},{"date":"2024-11-08","current":29.463901,"twenty":25.512651,"median":29.272452,"eighty":33.684759,"marketCap":56465859000},{"date":"2024-11-15","current":26.265769,"twenty":25.52529,"median":29.194481,"eighty":33.660087,"marketCap":49956390000},{"date":"2024-11-22","current":26.278217,"twenty":25.56015,"median":29.088985,"eighty":33.628618,"marketCap":49956390000},{"date":"2024-11-29","current":26.561468,"twenty":25.595136,"median":29.046664,"eighty":33.578085,"marketCap":50461000000},{"date":"2024-12-06","current":27.316407,"twenty":25.595136,"median":28.89327,"eighty":33.512207,"marketCap":51772986000},{"date":"2024-12-13","current":27.527865,"twenty":25.608792,"median":28.855293,"eighty":33.470601,"marketCap":52126213000},{"date":"2024-12-20","current":27.519045,"twenty":25.66112,"median":28.7635,"eighty":33.433798,"marketCap":51823447000},{"date":"2024-12-27","current":26.95045,"twenty":25.695677,"median":28.729978,"eighty":33.410147,"marketCap":50713305000},{"date":"2025-01-03","current":25.718533,"twenty":25.700075,"median":28.694216,"eighty":33.386493,"marketCap":48442560000},{"date":"2025-01-10","current":26.596222,"twenty":25.605578,"median":28.598093,"eighty":33.385259,"marketCap":49905929000},{"date":"2025-01-17","current":28.4557,"twenty":25.610934,"median":28.581538,"eighty":33.383573,"marketCap":53438199000},{"date":"2025-01-24","current":29.058848,"twenty":25.694577,"median":28.62658,"eighty":33.365541,"marketCap":54912816000},{"date":"2025-01-28","current":30.995109,"twenty":25.696776,"median":28.668851,"eighty":33.362531,"marketCap":58878741600},{"date":"2025-02-07","current":31.279146,"twenty":25.700576,"median":28.706002,"eighty":33.347316,"marketCap":59082122400},{"date":"2025-02-14","current":32.46032,"twenty":25.708209,"median":28.7635,"eighty":33.295849,"marketCap":61166775600},{"date":"2025-02-21","current":32.605291,"twenty":25.726297,"median":28.850334,"eighty":33.213923,"marketCap":61776918000},{"date":"2025-02-28","current":33.709306,"twenty":25.745773,"median":28.875802,"eighty":33.347316,"marketCap":63658190400},{"date":"2025-03-07","current":37.167941,"twenty":25.761386,"median":29.014465,"eighty":33.385999,"marketCap":70471447200},{"date":"2025-03-14","current":37.985438,"twenty":25.781535,"median":29.070262,"eighty":33.525362,"marketCap":72047648400},{"date":"2025-03-21","current":37.329923,"twenty":25.803863,"median":29.089974,"eighty":33.667635,"marketCap":70776518400},{"date":"2025-03-28","current":31.329348,"twenty":25.820414,"median":29.153791,"eighty":33.6911,"marketCap":69149472000},{"date":"2025-04-03","current":32.960917,"twenty":25.84406,"median":29.176551,"eighty":33.68679,"marketCap":72606945600}],"updateTime":1744061575462}}}